|
News
Release
FOR IMMEDIATE RELEASE
March 5, 2003
Publication
Of Notice Of Proposed Rulemaking To Adjust Controlled Substances Registration
And Reregistration Fees
The
Drug Enforcement Adminstration (DEA) has submitted to the Federal Register
for publication a Notice of Proposed Rulemaking (NPRM) entitled "Controlled
Substances Registration and Reregistration Application Fees. The DEA is
publishing this NPRM to propose adjusting the current fee schedule for
DEA Controlled Substances Registration to adequately recover necessary
costs associated with the Diversion Control Program(DCP). The DEA published
its last fee revision in 1993. Fees have remained unchanged since that
time as the DEA resolved litigation regarding these fees.
Since the last published
rule adjusting the fees in 1993, the DCP has experienced significant growth
without any associated increase in registration fees to support the growth
and increased funding needs. The DEA is required by law to collect the
full costs of the DCP. The fee increases proposed in this rulemaking are
required to recoup ongoing program expenses which have been affected by
inflation and program activities. In addition the new fees will provide
funding for congressionally approved enhancements.
The proposed fees
are as follows:
|
Business
Activity
|
Current
Annual Cost
|
Proposed Annual Cost
|
|
Manufacturer
|
$875.00
|
$1,605.00
|
|
Distributor
|
$438.00
|
$804.00
|
|
Dispensing
or Instructing
|
$70.00
|
$391.00/3
years
|
|
(Includes
practitioner,
Hospital/clinic, retail
Pharmacy, teaching
Institiution)
|
|
|
|
Researcher
- Schedule I
|
$70.00
|
$131.00
|
|
Researcher
- Schedule II-V
|
$70.00
|
$131.00
|
|
Narcotic
Treatment Program
|
$70.00
|
$131.00
|
|
(Including
compounder)
|
|
|
|
Importer
|
$438.00
|
$804.00
|
|
Exporter
|
$438.00
|
$804.00
|
|
Analytical
Laboratory
|
$70.00
|
$131.00
|
|
Disposer
|
$70.00
|
$131.00
|
Registrants are encouraged
to read the proposal in the Federal Register publication dated February
17, 2003. Written comments must be submitted no later than 60 days after
the Federal Register publication. Written comments should be submitted
to the Administrator, Drug Enforcement Adminstration, Washington, DC 20537,
Attention: DEA Federal Register Representative/CCR. For further information,
contact Patricia M. Good, Chief Liaison and Policy Section, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537;
Telephone (202) 307-7297.
|